New One-Dose Meningitis Treatment 'Effective, Safer', Study Finds

According to a study, a new short-course treatment is effective against HIV-associated cryptococcal meningitis with fewer serious side effects, and has the potential to reduce the length and cost of hospital admissions, SciDev reports.

According to estimates produced by the London School of Hygiene and Tropical Medicine, cryptococcal meningitis, a fungal infection which invades the lining of the brain, kills over 180,00 every year globally, with 75% of deaths occurring in Sub-Saharan Africa.

Joseph Jarvis, lead author and a research associate at the Botswana Harvard AIDS Partnership Institute, says that cryptococcal meningitis is a severe disease in people with HIV, and is the most common cause of meningitis in adults, especially in East and Southern Africa. It causes about 15% of all deaths related to HIV globally.


Members of MSF Nigeria Emergency Response Unit (NERU) precede to make the triage to the people arriving in the meningitis treatment center run by MSF in Sokoto Mutalah Mohamad Hospital (file photo).

Follow AllAfrica

AllAfrica publishes around 700 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.